Candel Therapeutics Inc (CADL)

8.80 +0.17 (+1.97%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Candel Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Pfizer Inc Upgrade
AnaptysBio Inc --
Bristol-Myers Squibb Co Upgrade
Inovio Pharmaceuticals Inc --
NovaBay Pharmaceuticals Inc --